August 20, 2014

Why New Antidepressant Brintellix May Be a Killer

pin it button Why New Antidepressant Brintellix May Be a Killer

Brintellix and Death Caduceus Why New Antidepressant Brintellix May Be a Killer

by Heidi Stevenson
Gaia-Health.com

Brintellix is being marketed with implications that it’s the best antidepressent yet and that it’s exceptionally safe. What is this based on? Close examination shows the usual smoke and mirrors, and an even closer look points out disturbing indications of potentially devastating and deadly effects—with no indication that it’s better than existing SSRIs, which are known killers.

One of the most devastating classes of drugs ever developed is antidepressant SSRIs, selective serotonin receptor inhibitors. Not only can they destroy your own life, but they can also turn you into a murderer. Now, the FDA has approved Brintellix, which may prove to be the worst of them all.

In a press release by pharmaceutical company Lundbeck, the developer of Brintellix[1], it’s admitted that the cause of depression is unknown. Nonetheless, they cavalierly play with brain chemistry about which they know very little. Making this particular drug potentially even worse than any other SSRI is that it doesn’t limit itself to one or two pathways in the brain. It manipulates a total of 6 receptors!

Although Takeda Pharmaceuticals and Lundbeck, the US distributors, are expecting Brintellix to become a blockbuster drug, the hyped studies that appear to demonstrate both efficacy and safety are far from the full story. In fact, some studies have shown no benefit over placebo whatsoever.[2] It’s apparent from their approval announcement that the FDA did not take studies with negative results into account. They referred to only 6 studies, which the agency states, “demonstrated that Brintellix is effective in treating depression”.[3]

SSRIs

SSRIs do not work as claimed. They interfere with normal brain functioning. They don’t stop depression. Instead, they stop the ability to feel emotions. They result in emotional flatness. Some people may find that beneficial, something of a time-out. But it never resolves the problems that lead to depression, and even interferes with resolution. How can anyone resolve a problem when a drug interferes with their ability to even know that it’s there?

All SSRIs do the same thing. They prevent serotonin, also called 5-HT, from being reabsorbed, as their name, selective “serotonin reuptake inhibitors”, indicates. That hasn’t turned out well. These drugs are now known to cause previously nonsuicidal people to take their own lives without warning. They have also made many people violent and are associated with almost all school shootings.

There is little reason to believe that Brintellix will be more effective than other SSRI antidepressants. In fact, the more SSRIs manage to shut down serotonin production, the more harm they do. The brain works to counter the effect. As Dr. Peter Brennan notes, it can result in permanent brain damage.[4]

In fact, the Los Angeles Time reported that Dr. Michael Thase, a Brintellix development consultant, stated:

It is different enough from the welter of SSRIs currently available that it’s not simply a ‘me too’ drug.[5]

That’s likely true, but does that  make it better?

Brintellix May Be Even Worse

Inexplicable violence, turned both inward and outward, is the result of SSRIs causing a single change to brain function. Brintellix will cause several changes! These changes involve the handling of glutamate, which is a critical amino acid that’s required for brain function and cellular metabolism. Glutamate is necessary—at proper levels, in the right places, and at the right times—for learning, remembering, thinking, and emotions. It’s also involved in energy production throughout the body.

Glutamate excites neural function. Too much glutamate can burn nerves out and too little keeps them from functioning properly. Not only does Brintellix manipulate 5-HT (serotonin), like all other SSRIs, it also manipulates glutamate in several neural receptors:

  • 5-HT1A: Agonist
  • 5-HT1B: Partial Agonist
  • 5-HT3: Antagonist
  • 5-HT1D: Antagonist
  • 5-HT7: Antagonist

Note: An agonist triggers a response from a cell. An antagonist does the opposite. It blocks a cell’s response.

Does anyone really know what the effects of this manipulation of neural transmission will be?

No. Here is what the manufacturer’s press release announcing Brintellix’s approval says about it:

The contribution of each of these activities to Brintellix’s antidepressant effect has not been established. It is considered to be the first and only compound with this combination of pharmacodynamic activity. The clinical relevance of this is unknown.

Let’s look at that again:

No one knows what relationship exists between any of these neural receptors and Brintellix’s effect.

No one knows what these manipulations of the brain will do to the body, intelligence, emotional state, sexuality, criminality, empathy, or anything else.

Nearly all the effects of Brintellix are unknown.

How Much Harm?

Like so many drugs, Brintellix is being rolled out as safe. Like others, that safety is based on a very slim thread: short term studies, which evade the risks. The existing studies produced by Lundbeck are short term, and many adverse effects take time to be seen. They’re also based on a small number of subjects. Most severe adverse effects don’t show up in such studies.

At this point, the list of adverse effects is both brief and appears to be fairly minor. Medscape[6]reports the following adverse effects, followed by the percentage who suffered it:

  • Nausea: 21-32%
  • Diarrhea: 7-10%
  • Dizziness: 6-9%
  • Dry mouth: 6-8%
  • Constipation: 3-6%
  • Vomiting: 3-6%
  • Flatulence: 1-3%
  • Pruritus: 1-3%
  • Abnormal Dreams: Less than 1-3%

These adverse effects are not as innocent as they first appear. Notice that as many as a third of the subjects suffered from nausea, and other gastrointestinal effects were not unusual. This is a red flag that there may be a dangerous adverse effect on the digestive tract that doesn’t show up quickly—not something to take lightly.

Dizziness and abnormal dreams are indicative of very serious harmful neurological effects. Pruritus is a neurologically-induced extreme urge to scratch an itch. This symptom is also indicative of neurological damage. Even at this early stage, the adverse effects point to the potential of severe and dangerous, potentially deadly, reactions.

The history of all other SSRIs, which interfere with only one specific function, has been dismal. Is there any reason to expect Brintellix to be different? The studies certainly aren’t more extensive than they’ve been with other SSRIs, so the reality is that, as usual, the people whose doctors prescribe it will be the guinea pigs.

If your doctor tries to prescribe Brintellix, perhaps the correct response should be, “Oink!”

Even Big Pharma’s faithful lapdog called the FDA has acknowledged some risk. They’re requiring a boxed warning that people younger than 24 years are at risk of developing suicidal thoughts. This, of course, is meaningless. All SSRIs carry that warning, and it certainly doesn’t seem to have reduced prescription levels!

SSRI = Killer

As the FDA admits, all SSRI drugs are known to be killers, and worse than most drugs, they can result in the deaths of people who don’t even take them! They are implicated in virtually all the school shootings. That’s a lot of carnage.

Brintellix is an SSRI. Is there any reason to believe that it will produce less harm than other SSRIs? In fact, there is every reason to suspect the opposite.

By its developer’s own admission, no one knows what effects are produced by 5 of the 6 functions Brintellix was designed to cause. But we do know that the 6th function, serotonin/5-HT reuptake inhibition, is a killer. All of the other 5 functions interfere with normal brain activity—and the manufacturer admits that no one knows what those effects will be!

 What more do you need to know?

Read the full article here: http://gaia-health.com/gaia-blog/2013-10-04/why-new-antidepressant-brintellix-may-be-a-killer/

Sources:

  1. Takeda and Lundbeck announce FDA approval of Brintellix™ (vortioxetine) for treatment of adults with major depressive disorder. Lundbeck’s Brintellix press release.
  2. Antidepressant – vortioxetine. Manufacturer’s Chemist’s review of Brintellix.
  3. FDA approves new drug to treat major depressive disorder. FDA’s Brintellix approval announcement.
  4. Psychiatric drug-induced Chronic Brain Impairment (CBI): Implications for longterm treatment with psychiatric medicationInternational Journal of Risk and Safety in Medicine; DOI 10.3233/JRS-2011-0542.
  5. FDA approves a new antidepressant: BrintellixLos Angeles Times.
  6. Vortioxetine Adverse Effects; Medscape Reference.
  7. Vortioxetine (Lu AA21004) hydrobromide.
  8. Glutamate.
  9. Glutamate benefit and side effects, risk and danger.
  10. Vortioxetine: A New Antidepressant Choice in the United States

The Emperor’s New Drugs
Exploding the Antidepressant Myth
by Irving Kirsch Ph.D.

The Emperors New Drugs Book cover 202x300 Why New Antidepressant Brintellix May Be a Killer

Free Shipping Available!
More Info


0 commentsback to post

Other articlesgo to homepage

Will India be First Country to Revoke Marketing Licenses for HPV Vaccines?

Will India be First Country to Revoke Marketing Licenses for HPV Vaccines?

Pin It

A petition currently before the Supreme Court of India alleges that the Drugs Controller of India issued licenses for Gardasil and Cervarix without adequate research on safety as directed by the Parliamentary Standing Committee on Health and Family Welfare.

Petition number 558/2012, filed by Kalpana Mehta, Nalini Bhanot and V. Rukmini Rao, seeks to resolve this and several other issues by asking the Supreme Court of India to rescind the licenses for marketing and administration of HPV vaccines, make provisions to identify and treat any girls left with chronic health problems and/or autoimmune disorders after their participation in HPV vaccine trials, blacklist the Program for Appropriate Technology in Health (PATH), and allow no other foreign agencies to have a field presence in India.

Will India be the first country in the world to revoke the marketing licenses for Gardasil and Cervarix? Will the Supreme Court of India move to protect the health and welfare of their young citizens, or the interests of the HPV vaccine manufacturers? Will PATH and similar agencies be banned from operating in India?
Will the victims of adverse reactions to HPV vaccines be located and treated? We can only hope these questions will be answered when the final hearing will take place.

CDC Whistleblower: CDC Covered Up MMR Vaccine Link to Autism in African American Boys

CDC Whistleblower: CDC Covered Up MMR Vaccine Link to Autism in African American Boys

Pin It

A top research scientist working for the Centers for Disease Control and Prevention (CDC) played a key role in helping Dr. Brian Hooker of the Focus Autism Foundation uncover data manipulation by the CDC that obscured a higher incidence of autism in African-American boys.

“We’ve missed ten years of research because the CDC is so paralyzed right now by anything related to autism. They’re not doing what they should be doing because they’re afraid to look for things that might be associated.” The whistleblower alleges criminal wrongdoing of his supervisors, and he expressed deep regret about his role in helping the CDC hide data.

The Cancer Industry is Too Prosperous to Allow a Cure

The Cancer Industry is Too Prosperous to Allow a Cure

Pin It

We have lost the war on cancer. At the beginning of the last century, one person in twenty would get cancer. In the 1940s it was one out of every sixteen people. In the 1970s it was one person out of ten. Today one person out of three gets cancer in the course of their life.

The cancer industry is probably the most prosperous business in the United States. In 2014, there will be an estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer deaths in the US. $6 billion of tax-payer funds are cycled through various federal agencies for cancer research, such as the National Cancer Institute (NCI). The NCI states that the medical costs of cancer care are $125 billion, with a projected 39 percent increase to $173 billion by 2020.

The simple fact is that the cancer industry employs too many people and produces too much income to allow a cure to be found. All of the current research on cancer drugs is based on the premise that the cancer market will grow, not shrink.

John Thomas explains to us why the current cancer industry prospers while treating cancer, but cannot afford to cure it.

800,000 Die from Blindly Trusting Their Doctor’s Prescription for This Pre-Surgery Drug

800,000 Die from Blindly Trusting Their Doctor’s Prescription for This Pre-Surgery Drug

Pin It

European doctors may have caused as many as 800,000 deaths in five years by following the “standard of care” to use beta-blockers in non-cardiac surgery patients—a guideline based largely on discredited science.

Tylenol: The Killer Drug Your Children can Buy

Tylenol: The Killer Drug Your Children can Buy

Pin It

Is there any more doubt that acetaminophen (Tylenol) is the most dangerous over-the-counter drug ever allowed to be sold legally without a prescription? Consider the facts:

Acetaminophen kills almost 500 people a year due to acute liver failure.
Acetaminophen overdose is the leading cause for calls to Poison Control Centers – more than 100,000/year.
Acetaminophen accounts for more than 56,000 emergency room visits, 2,600 hospitalizations.
Acetaminophen poisoning causes nearly 50% of all acute liver failure in the United States.
Acetaminophen is linked to fatal skin reactions.
Acetaminophen causes a two-fold increased risk of blood cancer.
Acetaminophen can cause an increase in autism, attention deficit with hyperactivity, and asthma when used with vaccines.

And yet, any child can walk into a drug store or grocery store and buy it like candy. Alliance for Natural Health brings us the latest bad news on Tylenol:

A study just published in JAMA Pediatrics finds that Tylenol (acetaminophen) taken by women during their pregnancy may raise the risk of ADHD (Attention Deficit Hyperactive Disorder) and similar disorders in their children up to 40%—with the risk increasing the more acetaminophen the mother takes.

read more


Get the news right in your inbox!